| | (Reuters) - GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies. | |
| WASHINGTON (Reuters) - As Hurricane Irma bore down on Florida last September, the top U.S. disaster-response official ordered all hands on deck. | |
| (Reuters) - Mylan NV said on Wednesday that U.S. health regulators were unable to approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug Advair for the second time, as they found "minor deficiencies" in the treatment. | |
| (Reuters) - Eli Lilly & Co said on Wednesday its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year. | |
| CHICAGO (Reuters) - An analysis of data on Sanofi's dengue vaccine, which has been given to more than 800,000 school children in the Philippines, confirms it increases the risk of hospitalization and severe dengue in those who had never previously been infected with the mosquito-borne virus. | |
| (Reuters Health) - People who do resistance exercises like weight lifting and strength training may experience fewer depression symptoms, a research review suggests. | |
| (Reuters Health) - Older women with higher levels of anxiety than their peers are also more likely to develop poor bone health that increases the risk of fractures, a small study suggests. | |
| (Reuters Health) - White women with breast cancer are more likely to complete their prescribed chemotherapy regimen than women of color, a U.S. study suggests. | |
| (Reuters Health) - Women could soon know how far along they are in pregnancy and their risk of premature delivery using simple blood tests, researchers say. | |
| SOFIA (Reuters) - An outbreak of a virulent bird flu virus has spread to another farm in northeastern Bulgaria, the national food safety agency said on Wednesday. | |
|
| |